| Bioactivity | Nimorazole (K-1900), a 2-nitroimidazole, is a hypoxic cell-radiation sensitizer. Nimorazole has anti-infective and anti-protozoal against trichomoniasis. Nimorazole has the potential for head and neck cancer[1][2]. | ||||||||||||
| Invitro | Nimorazole significantly improves the effect of radiotherapeutic management of supraglottic and pharynx tumors and can be given without major side-effects[1][2]. Nimorazole is the only such agent to have shown a significant effect in a randomized controlled trial in head and neck cancer[3]. | ||||||||||||
| Name | Nimorazole | ||||||||||||
| CAS | 6506-37-2 | ||||||||||||
| Formula | C9H14N4O3 | ||||||||||||
| Molar Mass | 226.23 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|